Job Description

INTRODUCTORY PARAGRAPH

At Evinova, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big, and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.

Evinova is a health-tech business , separate company within the AstraZeneca Group, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigor, and human experience-driven insight, our digital solutions are deliberately crafted so that everyone can reach better health outcomes together.

We are seeking a highly experienced and strategic Senior Director, Digital Health to join our growing team in China. This senior leadership role combines deep clinical development expertise, strategic account leadership, and a passion for digital innovation. You will play a pivotal role in shaping Evinova China's digital health strategy, leading our strategic partnership with AstraZeneca China R&D, driving adoption of innovative digital and AI-enabled solutions, and transforming how clinical trials are designed and delivered.

WHAT THE ROLE INVOLVES

The Senior Director, Digital Health is a key leadership role of Evinova China. This role will report directly to the General Manager of China, with a dotted line to the Global Head of Digital Health.

This role will work closely with the China GM to develop and execute Evinova China's Digital Health strategy, identify opportunities for differentiation, and translate the evolving needs of pharmaceutical R&D organizations into innovative digital health solutions, including China-specific requirements and localization.

The role will also serve as Key Account Manager (KAM) for AstraZeneca China, taking strategic ownership of the AstraZeneca China R&D relationship, strengthening executive engagement, identifying collaboration opportunities, and driving adoption of Evinova solutions across the AstraZeneca China R&D organization.

The focus of this role is to provide senior digital health and clinical leadership, working closely with Evinova's global Digital Health, Science, Product, and Commercial teams to develop strategies and implement digital and AI-enabled clinical development solutions.

Our mission is to:

· Transform clinical development through innovative, patient- and site-centric digital solutions that improve trial design, execution efficiency, patient access, and clinical outcomes.

· Improve patient safety and trial outcomes through remote patient monitoring, digital data collection, and proactive toxicity management, while generating enriched clinical evidence to support drug development.

You will:

· Lead Evinova China's Digital Health strategy, working closely with China and global leadership to identify market opportunities, prioritize clinical development needs, and drive the adoption of innovative digital and AI solutions.

· Serve as the strategic Key Account Manager for AstraZeneca China R&D, building trusted relationships with senior R&D executives and functional leaders, developing strategic account plans, identifying business opportunities, and driving long-term partnership growth and solution adoption.

· Provide senior clinical development expertise and strategic guidance on clinical trial design and execution, including protocol optimization, patient recruitment, operational feasibility, safety monitoring, and trial delivery.

· Work closely with pharmaceutical and biotechnology R&D leaders to understand clinical development challenges and develop differentiated digital strategies, leveraging Evinova's solutions across AI-enabled study design, remote patient monitoring, digital clinical outcome assessments, and patient engagement.

· Provide digital health and clinical leadership in treatment-related toxicity management, identifying opportunities to improve patient safety, trial efficiency, and clinical outcomes through digital monitoring solutions.

· Collaborate with Evinova's global Science and Product teams to translate customer requirements and clinical insights into product strategy and innovation priorities, particularly for Study Designer and Unify, ensuring scientific rigor, clinical relevance, and market differentiation.

· Build trusted relationships with senior pharmaceutical R&D executives, clinical development leaders, investigators, and external partners, acting as a strategic advisor and thought leader in digital clinical development.

· Partner with Business Development, Solution Consulting, and Customer Success teams to support strategic customer engagements, develop compelling clinical value propositions, and accelerate solution adoption and business growth.

· Champion digital health transformation by establishing best practices, building clinical and digital capabilities, and influencing stakeholders across functions and geographies to adopt innovative ways of working.

· Provide strategic oversight of key initiatives, ensuring effective governance, risk management, execution excellence, and delivery of measurable clinical and business outcomes.

Would you like to apply your clinical development expertise to transform how medicines are developed through digital innovation? Do you thrive at the intersection of science, technology, and business strategy? If you are passionate about shaping the future of clinical development and improving patients' lives, Evinova might be the right place for you!

SKILLS AND CAPABILITIES NEEDED

Minimum Qualifications

• Master's degree or above in Medicine, Pharmacy, Life Sciences, Clinical Research, Biomedical Sciences, or a related scientific discipline.
• 10+ years of professional experience in pharmaceutical R&D, biotechnology, or CRO organizations, with substantial experience in clinical development and clinical trial operations.
• 8+ years of direct oncology clinical development experience, with strong hands-on expertise in oncology clinical trial design, protocol development, study execution, and clinical development strategy.
• Proven track record of designing and executing complex oncology clinical trials, preferably Phase II–III studies, with direct involvement in protocol design, endpoint selection, patient eligibility criteria, study feasibility, and operational planning.
• Strong practical experience in oncology clinical trial execution, including site selection and management, patient recruitment and retention, investigator engagement, safety monitoring, clinical data quality, and study delivery.
• Deep understanding of oncology drug development, including targeted therapies, immunotherapies, antibody-drug conjugates (ADCs), bispecific antibodies, and emerging therapeutic modalities.
• Strong knowledge of oncology treatment-related adverse events and toxicity management, particularly pulmonary/ILD, gastrointestinal, and hematologic toxicities.
• Comprehensive understanding of clinical development processes, ICH-GCP, China NMPA/CDE requirements, and international clinical research standards.
• Solid knowledge of digital health technologies supporting clinical trials, including remote patient monitoring, eCOA/ePRO, decentralized clinical trials, and digital patient engagement.
• Strong understanding of AI applications in clinical development, particularly AI-enabled protocol design, trial optimization, and clinical trial execution.
• Demonstrated strategic leadership and ability to influence senior pharmaceutical R&D executives, clinical development leaders, and cross-functional stakeholders.
• Proven experience in strategic account management or senior-level customer relationship management, with the ability to build executive partnerships, identify business opportunities, and drive long-term customer value.
• Strong commercial acumen and customer orientation, with the ability to translate complex clinical challenges into strategic opportunities and compelling digital health value propositions.
• Proven experience leading cross-functional initiatives, managing strategic partnerships, and driving organizational change and innovation.
• Excellent communication, negotiation, problem-solving, and stakeholder management skills, with strong executive presence.
• Entrepreneurial mindset, high learning agility, strong ownership, and a results-driven attitude.
• Fluent in both English and Mandarin, with both used confidently as working languages.

Preferred Qualifications

• PhD or MD with advanced research training, preferably in Oncology, Clinical Medicine, Pharmaceutical Sciences, or a related discipline.
• Previous senior leadership role in Oncology Clinical Development, Clinical Operations, or Therapeutic Area Strategy within a leading pharmaceutical, biotechnology, or global CRO organization.
• Experience leading global or multinational oncology clinical trials, including China participation in global clinical development programs.
• Strong expertise in innovative oncology trial designs, including adaptive designs, biomarker-driven studies, and precision oncology.
• Experience with digital transformation of clinical development, particularly AI-enabled clinical trial design, remote patient monitoring, and digital toxicity management.
• Established relationships with leading oncology investigators, pharmaceutical R&D executives, and clinical research institutions in China.
• Experience managing strategic partnerships or key accounts within leading multinational pharmaceutical companies.
• Experience collaborating with technology, product, and commercial teams to develop and implement innovative clinical research solutions.
• Ability to work effectively in a global matrix organization, including international travel.

Why Evinova (AstraZeneca)?

Evinova draws on AstraZeneca’s deep experience developing novel therapeutics, informed by insights from thousands of patients and clinical researchers. Together, we can accelerate the delivery of life-changing medicines, improve the design and delivery of clinical trials for better patient experiences and outcomes, and think more holistically about patient care before, during, and after treatment. We know that regulators, healthcare professionals, and care teams at clinical trial sites do not want a fragmented approach. They do not want a future where every pharmaceutical company provides its own, different digital solutions. They want solutions that work across the sector, simplify their workload, and benefit patients broadly. By bringing our solutions to the wider healthcare community, we can help build more unified approaches to how we all develop and deploy digital technologies, better serving our teams, physicians, and ultimately patients. Evinova represents a unique opportunity to deliver meaningful outcomes with digital and AI to serve the wider healthcare community and create new standards for the sector. Join us on our journey of building a new kind of health tech business to reset expectations of what a bio-pharmaceutical company can be. This means we’re opening new ways to work, pioneering cutting-edge methods, and bringing unexpected teams together. Interested? Come and join our journey.

So, what’s next?

Are you already imagining yourself joining our team? Good, because we can’t wait to hear from you.

Where can I find out more?

Our Social Media, Follow Evinova on LinkedIn https://www.linkedin.com/company/evinova/

Learn more about Evinova www.evinova.com

Date Posted

30-10月-2026

Closing Date

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.